Doctors Discover Drug Already on the Market ‘Could Prevent 1 Million New Cases of Alzheimer’s’ a Year

Alzheimer’s affects nearly 7 million Americans, a number that’s expected to spike to 13.9 million by 2060.

Given the devastating effects of this incurable disease, the hunt is on for a drug that could help prevent or slow its progression.

Now, a new study has found that nucleoside reverse transcriptase inhibitors (NRTIs) — a common class of medications for HIV — could dramatically decrease the risk of developing this neurodegenerative disorder.

Analyzing data from over 270,000 patients aged 50 and older, researchers observed that the risk of Alzheimer’s decreased by 6% to 13% for each year the patients were on NRTIs.

These results are — to say the least — incredibly promising.

“It’s estimated that over 10 million people around the world develop Alzheimer’s disease annually,” said Jayakrishna Ambati, founding director of the University of Virginia Center for Advanced Vision Science. (Read more from “Doctors Discover Drug Already on the Market ‘Could Prevent 1 Million New Cases of Alzheimer’s’ a Year” HERE)

Photo credit: Flickr